- Home
- PAVS vs NSPR Comparison
PAVS vs NSPR Comparison
Compare PAVS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- NSPR
- Stock Information
- Founded
- PAVS 2004
- NSPR 2005
- Country
- PAVS United States
- NSPR United States
- Employees
- PAVS N/A
- NSPR N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- NSPR Medical/Dental Instruments
- Sector
- PAVS Health Care
- NSPR Health Care
- Exchange
- PAVS Nasdaq
- NSPR Nasdaq
- Market Cap
- PAVS 89.6M
- NSPR 75.6M
- IPO Year
- PAVS 2019
- NSPR N/A
- Fundamental
- Price
- PAVS $1.33
- NSPR $2.59
- Analyst Decision
- PAVS
- NSPR Strong Buy
- Analyst Count
- PAVS 0
- NSPR 2
- Target Price
- PAVS N/A
- NSPR $4.75
- AVG Volume (30 Days)
- PAVS 6.8K
- NSPR 52.1K
- Earning Date
- PAVS 01-01-0001
- NSPR 05-13-2025
- Dividend Yield
- PAVS N/A
- NSPR N/A
- EPS Growth
- PAVS N/A
- NSPR N/A
- EPS
- PAVS N/A
- NSPR N/A
- Revenue
- PAVS $6,544,819.00
- NSPR $7,009,000.00
- Revenue This Year
- PAVS N/A
- NSPR $28.93
- Revenue Next Year
- PAVS N/A
- NSPR $172.18
- P/E Ratio
- PAVS N/A
- NSPR N/A
- Revenue Growth
- PAVS N/A
- NSPR 12.96
- 52 Week Low
- PAVS $0.32
- NSPR $1.81
- 52 Week High
- PAVS $1.50
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- PAVS 43.14
- NSPR 44.84
- Support Level
- PAVS $1.29
- NSPR $2.37
- Resistance Level
- PAVS $1.40
- NSPR $2.68
- Average True Range (ATR)
- PAVS 0.05
- NSPR 0.17
- MACD
- PAVS -0.00
- NSPR 0.00
- Stochastic Oscillator
- PAVS 66.67
- NSPR 77.36
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.